-
2 weeks ago | 
mdpi.com | Qiang Zhang |Xiangrong Li |Zhipeng Li |Yang Xu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Dec 10, 2024 | 
mdpi.com | Qi Wang |Chenglin Yan |Yahui Zhang |Yang Xu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Dec 10, 2024 | 
ascpt.onlinelibrary.wiley.com | Yang Xu |Xinyu Li |Qixiang Guo |Qi Chen
CONFLICT OF INTEREST The authors declared no competing interests for this work. Supporting Information Filename Description cpt3511-sup-0001-Supinfo.docxWord 2007 document , 1 MB Appendix S1. Appendix S2. Appendix S3. Appendix S4. Appendix S5. Appendix S6. Table S1. Table S2. Table S3. Table S4. Table S5. Table S6. Table S7. Table S8. Table S9. Table S10. Figure S1. Figure S2. Figure S3. Figure S4.
-
Nov 7, 2024 | 
arxiv.org | Yang Xu |Ran Zhang |Jiang Xie |Miao Wang
-
Oct 31, 2024 | 
mdpi.com | Xuhua Hu |Yang Xu |Peng Huang |Dan Yuan
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Oct 23, 2024 | 
mdpi.com | Peng Peng |Yang Xu |Li Yu |Xiaowei Xie
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Sep 12, 2024 | 
nature.com | Sizhao Lu |Yang Xu |Shouneng Peng |Adrien Georges |Aya Nomura-Kitabayashi |Robert Wiener | +5 more
AbstractFibromuscular dysplasia (FMD) is a poorly understood disease affecting 3–5% of adult females. The pathobiology of FMD involves arterial lesions of stenosis, dissection, tortuosity, dilation and aneurysm, which can lead to hypertension, stroke, myocardial infarction and even death. Currently, there are no animal models for FMD and few insights as to its pathobiology.
-
Aug 15, 2024 | 
pubs.acs.org | Yang Xu |Ye Lin |Simon L. Homölle |Lutz Ackermann
IntroductionClick to copy section linkSection link copied!Over the past decades, photochemistry has been identified as an environment-friendly platform for molecular synthesis. (1−9) The merger of photoinduced catalysis with enantioselective catalysis, (10−12) such as organocatalysis, (13−16) enzymatic catalysis, (17) and transition metal catalysis, (18,19) provides a powerful strategy to satisfy the growing demand for enantiomerically pure small molecules.
-
Jul 4, 2024 | 
nature.com | Yue You |Yang Xu |Guangdun Peng |Abhishek Kumar |Matthew Ritchie |Xiaodong Liu
AbstractRecent developments of sequencing-based spatial transcriptomics (sST) have catalyzed important advancements by facilitating transcriptome-scale spatial gene expression measurement. Despite this progress, efforts to comprehensively benchmark different platforms are currently lacking. The extant variability across technologies and datasets poses challenges in formulating standardized evaluation metrics.
-
May 5, 2024 | 
nature.com | He Huang |Yang Xu
AbstractsCoinfusion of unrelated cord blood (UCB) units in haploidentical hematopoietic cell transplantation (haplo-HCT) (haplo-cord HCT) for hematopoietic malignancies showed promising results in previous reports, but the efficiency of haplo-cord HCT in acute myeloid leukemia (AML) still lacks sufficient evidence. This multicenter, randomized, phase 3 trial (ClinicalTrials.gov NCT03719534) aimed to assess the efficacy and safety of haplo-cord HCT in AML patients.
